Trademark: 90812123
Word
AI IS WHERE THE DATA IS
Status Date
Tuesday, April 5, 2022
Registration Number
6693951
Registration Date
Tuesday, April 5, 2022
Filing Date
Tuesday, July 6, 2021
Published for Opposition
Tuesday, January 18, 2022
9 Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
35 Statistical services and modeling with respect to cancer treatment and cancer diagnosis
44 Medical and pharmaceutical services
42 Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
ARTIFICIAL INTELLIGENCE IS WHERE THE DATA IS
Nov 2, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 2, 2022
Teas Change Of Correspondence Received
Nov 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 2, 2022
Teas Change Of Owner Address Received
Apr 5, 2022
Registered-Principal Register
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 11, 2021
Approved For Pub - Principal Register
Dec 10, 2021
Teas/Email Correspondence Entered
Dec 10, 2021
Correspondence Received In Law Office
Dec 9, 2021
Assigned To Lie
Dec 6, 2021
Teas Response To Suspension Inquiry Received
Sep 21, 2021
Notification Of Letter Of Suspension E-Mailed
Sep 21, 2021
Letter Of Suspension E-Mailed
Sep 21, 2021
Suspension Letter Written
Sep 21, 2021
Assigned To Examiner
Sep 14, 2021
New Application Office Supplied Data Entered In Tram
Jul 9, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
